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Recognitionofcell deathby the innate immunesystem
triggers inflammatory responses.However, how these
reactions are regulated is not well understood. Here,
we identify the inhibitory C-type lectin receptor
Clec12a as a specific receptor for dead cells. Both
human and mouse Clec12a could physically sense
uric acid crystals (monosodium urate, MSU), which
are key danger signals for cell-death-induced immu-
nity. Clec12a inhibited inflammatory responses to
MSU in vitro, and Clec12a-deficient mice exhibited
hyperinflammatory responses after being challenged
withMSUor necrotic cells and after radiation-induced
thymocytekilling invivo.Thus,we identifiedanegative
regulatory MSU receptor that controls noninfectious
inflammation in response to cell death that has impli-
cations for autoimmunity and inflammatory disease.
INTRODUCTION
Several families of germline-encoded pattern-recognition recep-
tors (PRRs) can sense damage-associated molecular patterns
(DAMPs), which are exposed or released upon cell death under
sterile conditions. Subsequent immune signaling is important for
themaintenance of tissue homeostasis but can also drive immune
pathology when exacerbated (Kaczmarek et al., 2013; Kuraishy
et al., 2011; Zitvogel et al., 2010). Although DAMPs can induce
similar immune responses asmicrobial pathogen-associatedmo-
lecular patterns (PAMPs), the positive and negative regulation of
sterile inflammatory responses tocell death isnotwell understood.
One important class of PRRs that recognizes both DAMPs as
well as PAMPs is the myeloid C-type lectin receptors (CLRs),
which are organized in the Dectin-1 and Dectin-2 gene clusters
located within the natural killer gene complex. These receptors
are type II transmembrane proteins with single extracellular
C-type lectin domains that can sense a diverse array of distinct
ligands. A subset of these CLRs regulates immunity by activatingthe tyrosine kinase Syk through immunoreceptor tyrosine-based
activation motifs (ITAMs) or ITAM-like motifs. Subsequent Syk
signaling can drive inflammation through the production of reac-
tive oxygen species (ROS) and generation of cytokines and che-
mokines (Hardison and Brown, 2012; Sancho and Reis e Sousa,
2012, 2013; Wevers et al., 2013). Examples of Syk-activating
CLRs that sense DAMPs under noninfectious conditions are
Clec9a (DNGR-1), which detects filamentous actin exposed by
dead cells (Ahrens et al., 2012; Zhang et al., 2012), and Mincle
(Clec4E), which recognizes the spliceosome-associated protein
SAP-130 (SF3B3) upon cell damage (Yamasaki et al., 2008).
To prevent inappropriate immune responses, cell-activating
Syk signals are, in general, counterbalanced by negative regu-
latory receptors containing immunoreceptor tyrosine-based
inhibitory motifs (ITIMs) (Long, 2008). Clec12a (MICL, DCAL2, or
CLL-1) is a poorly characterized ITIM-containing CLR encoded
within the Dectin-1 cluster. This receptor binds unknown endog-
enous ligands and is widely expressed on innate immune cells,
including neutrophils, monocytes, macrophages, and dendritic
cells. Its intracellular ITIM sequence recruits the tyrosine phos-
phatases SHP-1 and SHP-2 to negatively regulate Syk signaling
(Marshall et al., 2004). Because the expression of Clec12a can
be downregulated under inflammatory conditions, this receptor
might be involved in thecontrol ofmyeloid cell activation (Marshall
et al., 2006;Pyz et al., 2008).However, thephysiological functions
of Clec12a and the identities of its ligands are unclear.
Here,we report thatClec12asensesdeadcells, andwe identify
uric acid crystals (MSU) as specific ligands of Clec12a. By using
Clec12a-deficient mice, we demonstrate that Clec12a inhibited
Syk-dependent neutrophil activation byMSU in vitro and immune
cell recruitment after MSU challenge or sterile cell death in vivo.
These findings provide a mechanism for the negative regulation
of noninfectious inflammation and new insights into how the
innate immune system responds to uric acid crystals.RESULTS
Clec12a Is a Receptor that Recognizes Dead Cells
To identify Clec12a ligands, we created CLR fusion proteins con-
sisting of murine or human Clec12a extracellular domains andImmunity 40, 389–399, March 20, 2014 ª2014 Elsevier Inc. 389
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Figure 1. Clec12a Binds to Dead Cells
(A) Schematic representation of recombinant CLR-Fc fusion proteins.
(B) HEK293 cells were killed by serum starvation or UV light, followed by incubation for 16 hr at 37C or freeze thawing, and stained with indicated CLR-Fc fusion
proteins and anti-human Fc-PE and 7-AAD and were then analyzed by flow cytometry.
(C) Mouse thymocytes were left untreated or subjected to a freeze-thaw cycle, stained, and analyzed as in (B). Untreated (viable) cells were gated on 7-AAD-
negative cells, and freeze-thawed (dead) cells were gated on 7-AAD-positive cells.
(D) The indicated tissues weremechanically disrupted using a cell strainer, and thymocytes and splenocytes were subjected to a freeze-thaw cycle to kill the cells
and then stained and analyzed as in (B). The fraction of dead cells (7-AAD+) binding to CLR-Fc fusion proteins is shown. All data are representative of at least three
independent experiments.
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Clec12a Senses Uric Acid Crystalsthe Fc portion of human immunoglobulin G (IgG) (mClec12a-Fc,
hClec12a-Fc) (Figure 1A). Analogous fusions were created for
the b-glucan receptor, Clec7a (Dectin-1) (Brown and Gordon,
2001), or the dead cell receptor, Clec9a (Sancho et al., 2009).
To test whether Clec12a would also bind to dead cells, we killed
HEK293 cells by serum starvation, UV radiation, or a freeze-thaw
cycle and then stained these cells with CLR-Fc proteins with 7-
AAD to discriminate dead cell. Flow cytometry analysis revealed
that both murine and human Clec12a-Fc specifically recognized
7-AAD+ cells but did not bind to viable HEK293 cells (Figure 1B).
As expected, Clec9a-Fc also bound to dead cells but not to390 Immunity 40, 389–399, March 20, 2014 ª2014 Elsevier Inc.viable cells, and Clec7a-Fc bound only to the b-glucan-rich
fungal cell wall preparation, zymosan.
Next, we costained primary thymocytes with the CLR-Fc pro-
teins and 7-AAD. Similar to Clec9a-Fc, the Clec12a-Fc fusions
again specifically bound 7-AAD-positive dead cells, whereas
Clec7a-Fc did not recognize dead or viable thymocytes (Fig-
ure 1C). Next, we meshed murine spleens, kidneys, livers,
and hearts and then stained the cell suspensions with the
CLR-Fc fusions and 7-AAD. We observed that Clec12a recog-
nized dead cells from all of the tested tissues, with the highest
levels of binding observed for kidney tissue (Figure 1D). Thus,
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Figure 2. Dead Cells Activate Clec12a
(A) Clec12a-CD3z-expressing A5 NFAT-GFP reporter cells were incubated with or without polyclonal anti-mouse Clec12a rabbit serum. Eighteen hours later, the
viable cells (7-AAD) were analyzed for GFP expression by flow cytometry.
(B) A5 reporter cells expressing the indicated CLR-CD3z fusion proteins were cultured for 4 days without changing the growth medium. GFP fluorescence of the
live cells (left panel) and the fraction of dead (7-AAD+) cells (right panel) were analyzed each day by flow cytometry. MFI, mean fluorescence intensity.
(C) A5 reporter cells expressing the indicated CLR-CD3z fusion proteins were incubated with mouse kidney cells, which were isolated by mechanical disruption
using a cell strainer. Twenty hours later, the GFP expression of viable (7-AAD) reporter cells was analyzed by flow cytometry.
(D) Mouse kidney cells were isolated by collagenase digestion of kidney tissue. The cells were either left untreated or killed by freeze-thawing. The cells were
stained with indicated CLR-Fc fusion proteins and anti-human Fc-PE and 7-AAD and analyzed by flow cytometry.
(E) Both cell preparations from (D) were added to A5 reporter cells expressing the indicated CLR-CD3z fusion proteins. Twenty hours later, the A5 reporter cells
were analyzed by flow cytometry for GFP expression. All data are representative of at least three independent experiments.
Immunity
Clec12a Senses Uric Acid CrystalsClec12a binds structures that are formed or exposed after cell
death.
Dead Cells Can Crosslink Clec12a
After identifying the specific binding of Clec12a to dead cells, we
determined whether dead cells would also be able to crosslink
Clec12a on the surface of cells. Therefore, we created cellular
reporter systems based on the T cell hybridoma A5 (Bot et al.,
1996), which contains NFAT-controlled green fluorescent pro-
tein (GFP) expression cassettes, that were stably transfected
with fusions of the indicated CLR extracellular and trans-
membrane domains (Clec7a, Clec9a, mClec12a, or hClec12a)
coupled to the cytoplasmic signaling tail of CD3z. The ligation
of the CLR-CD3z fusion proteins signals NFAT activation, which
subsequently results in GFP expression (Andersen et al., 2001).
We stimulated mClec12a-CD3z reporter cells as a positive
control with a crosslinking mClec12a antibody. This treatment
induced GFP fluorescence in the reporter cells (Figure 2A).
Culturing reporter cell lines for a prolonged period of timewithout
media exchange also induced GFP fluorescence in the Clec12a-CD3z- and Clec9a-CD3z-expressing cells but not in the Clec7a-
CD3z reporters. The increase in the number of GFP-positive
cells paralleled the increasing numbers of dead cells in the cul-
tures (Figure 2B), suggesting that dead cells triggered Clec12a
crosslinking.
Next, we directly stimulated fresh reporter cells with mechan-
ically disruptedmouse tissue.We also observed the activation of
GFP expression in Clec12a-CD3z and Clec9a-CD3z reporter
cells but not in Clec7a-CD3z reporter cells (Figure 2C; data not
shown). Again, the most robust GFP activation was observed
upon stimulation with kidney tissue. To directly test whether
the presence of dead cells was responsible for the stimulation
of Clec12a, we prepared viable kidney cell suspensions by treat-
ing the organs with collagenase. Then, we killed a fraction of the
cells in vitro. Consistent with above findings, both Clec12a and
Clec9a only bound to dead cells (Figure 2D). Subsequent
reporter cell stimulation demonstrated that only the dead cell
fraction, but not the viable cell fraction, specifically activated
mClec12a-CD3z and hClec12a-CD3z signaling, as well as
Clec9a-CD3z signaling (Figure 2E). Together, these experimentsImmunity 40, 389–399, March 20, 2014 ª2014 Elsevier Inc. 391
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Clec12a Senses Uric Acid Crystalsdemonstrate that Clec12a functions as an immune receptor that
recognizes endogenous ligands that are generated or exposed
upon cell death and that Clec12a therefore shares some similar-
ities with Clec9a and Mincle.
Clec12a Is a Receptor for Uric Acid Crystals
Several structurally unrelated molecules alert the immune sys-
tem to dying cells. These DAMPs include nucleic acids and pro-
teins, including HMGB1, as well as uric acid crystals (Kaczmarek
et al., 2013; Zitvogel et al., 2010). To get insights into identities of
Clec12a ligands, we treated killed kidney cells with DNase or
RNase to degrade nucleic acids, with trypsin to digest proteins,
or with allopurinol to inhibit uric acid synthesis. Interestingly, only
the protein digestion or pharmacological inhibition of uric acid
synthesis reduced Clec12a-CD3z-mediated GFP induction (Fig-
ure 3A). To test the role of uric acid for Clec12a binding to dead
cells we incubated freeze-thawed cells with Rasburicase, an
enzyme that oxidizes uric acid to allantoin. This treatment specif-
ically reducedClec12a-Fc binding to dead cells, while Clec9a-Fc
binding was not affected (Figure 3B), indicating that Clec12a
binding to dead cells is at least in part dependent on uric acid.
The enzyme xanthine oxidase produces uric acid during
purine catabolism in a process that continues after cell injury
(Kono et al., 2010). Uric acid is soluble within intact cells, but
when cells lose their membrane integrity and high uric acid con-
centrations come into contact with high extracellular concentra-
tions of sodium ions, monosodium urate (MSU) microcrystals
can form. To test the hypothesis that Clec12a could directly
bind MSU crystals, we incubated mClec12a-Fc, hClec12a-Fc,
or mClec7a-Fc fusion proteins with MSU crystals or b-glucan
particles (curdlan) as a control. Surprisingly, by using fluorescent
microscopy, we observed that both human andmurine Clec12a-
Fc fusions bound specifically to uric acid crystals, whereas
mClec7a-Fc selectively recognized b-glucan, as expected
(Figure 3C).
Next, we utilized a flow cytometer to further characterize
the MSU-Clec12a interaction. Again, both mClec12a-Fc and
hClec12a-Fc specifically bound to MSU crystals, whereas
mClec7a-Fc selectively interacted with zymosan, and Clec9a-
Fc did not bind toMSU or zymosan (Figure 3D). To validate these
results, we created an additional set of independent CLR fusion
proteins by coupling the ligand-binding domains of hClec12a,
mClec12a, mClec7a, or mClec9a to strep-tagged isoleucine
zipper motifs (CLR-Strep) (Stark et al., 2005). We also observedFigure 3. Clec12a Is a Receptor for Uric Acid Crystals
(A) Freeze-thawed mouse kidney cells were incubated with RNase A (10 mg/ml),
subsequently added to Clec12a-CD3z reporter cells. Twenty hours later, the GFP
The means of three dead cell preparations + SD are shown.
(B) HEK293 cells were killed by freeze-thawing and incubated with or without 0.3
human Fc-PE and analyzed by flow cytometry.
(C) The indicated Fc fusion proteins were incubated with uric acid crystals (MSU) o
anti-human Fc-CF568, and the particles were analyzed by fluorescence microsc
(D)MSU or zymosanwas stained with CLR-Fc fusion or CLR-Strep fusion proteins
Strep-tagged proteins were detected with streptactin-PE using a flow cytometer
(E) A5 reporter cells expressing the indicated CLR-CD3 fusions were incubated
(250 mg/ml), curdlan (500 mg/ml), silica (500 mg/ml), calcium pyrophosphate dihyd
GFP fluorescence wasmeasured 16 hr later using a plate reader. Means + SD of tr
of at least three independent experiments.
See also Figure S1.that hClec12a-Strep and mClec12a-Strep bound specifically to
MSU crystals, whereas mClec7a-Strep bound to zymosan, and
mClec9a-Strep did not bind MSU or zymosan (Figure 3D),
demonstrating that the extracellular domains of both human
and murine Clec12a can specifically bind MSU. We tested
monoclonal antibodies raised against Clec12a and found a clone
that interferes with binding of recombinant Clec12a to MSU (see
Figure S1 available online), suggesting that Clec12a contains
a specific binding site for MSU close to the epitope of this
antibody.
To test whether MSU binding leads to Clec12a crosslinking,
we stimulated CLR-CD3z-expressing NFAT-GFP reporter cells
(Figure 3E). As anticipated, Clec7a-CD3z reporters activated
GFP expression only upon stimulation with zymosan or curdlan,
which is a selective Clec7a agonist, whereas Clec9a-CD3z
induced GFP fluorescence only upon stimulation with dead cells.
In contrast, mClec12a-CD3z and hClec12a-CD3z induced high
NFAT-GFP expression not only upon dead cell stimulation but
also upon selective stimulation with MSU crystals from two
different sources (Figure 3E). We also stimulated the cells with
other crystalline structures, such as silica and calcium pyrophos-
phate dihydrate (CPPD), which are known to activate immune
cells (Martinon et al., 2006). In contrast to MSU, these crystals
did not activate GFP expression in any of the reporter cells.
We therefore conclude that both murine and human Clec12a
can act as specific immune receptors for MSU and that MSU
can trigger Clec12a crosslinking in vitro.
Clec12a Downmodulates Neutrophil Activation in
Response to MSU
To investigate the physiological functions of Clec12a in MSU
sensing and dead cell recognition, we generated Clec12a-defi-
cient (Clec12a/) mice (Figure S2; Figure 4A). These animals
were viable, and they exhibited regular myeloid and lymphoid im-
mune cell compartments in the bone marrow, spleen, and lymph
nodes. There were no significant differences in the frequencies
and numbers of B and T cells, neutrophils, monocytes, or mac-
rophages between wild-type (WT) and Clec12a/ mice, and
these animals exhibited no obvious signs of pathology under
homeostatic conditions (Figure 4B; data not shown).
MSU can activate Syk signaling in immature myeloid cells,
neutrophils, or dendritic cells via a direct lipid membrane interac-
tion leading to ITAM receptor crosslinking or through a still-unde-
fined mechanism that involves the receptors CD16 and CD11bDNase I (50 U/ml), trypsin (100 mg/ml), or 1 mM allopurinol for 1 hr at 37C and
fluorescence of live (7-AAD) A5 reporter cells was analyzed by flow cytometry.
mg/ml Rasburicase, stained with indicated CLR-Fc fusion proteins and anti-
r curdlan (b-glucan) particles. Bound CLR-Fc fusion proteins were stained with
opy.
, as indicated. Bound Fc fusion proteins were detected with anti-human Fc, and
.
with self-crystallized (s) or commercial (c) MSU crystals (250 mg/ml), zymosan
rate (CPPD) (250 mg/ml), polystyrene beads (250 mg/ml), or dead kidney cells.
iplicates are shown. RFU, relative fluorescence units. All data are representative
Immunity 40, 389–399, March 20, 2014 ª2014 Elsevier Inc. 393
A B Figure 4. Generation of Clec12a Deficient
Mice
(A) Bone marrow from WT or Clec12a-deficient
(Clec12a/) mice was subjected to immunoblot
analysis using anti-Clec12a and anti-actin anti-
bodies.
(B) Splenocytes from WT or Clec12a-deficient
mice were stained for myeloid (Gr-1, Ly-6b.2,
CD11b and F4/80) and lymphoid markers (B220,
TcR, CD4 and CD8) and analyzed by flow cy-
tometry. The means of three mice per genotype +
SD are shown.
See also Figure S2.
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Clec12a Senses Uric Acid Crystals(Barabe´ et al., 1998; Desaulniers et al., 2001; Landis et al., 2002;
Ng et al., 2008). Consistently, pharmacological Syk inhibition
blocked the generation of ROS by MSU, as well as by zymosan
in bone-marrow cells (Figure 5A; data not shown). Because
Clec12a, as an ITIM receptor, has been shown to downmodulate
Syk signals (Marshall et al., 2004), we next tested the Syk-medi-
ated activation of Clec12a-deficient bone-marrow cells by using
ROS generation as a functional readout. Clec12a/ bone-
marrow cells produced regular dose-dependent amounts of
ROS upon Dectin-1 triggered Syk activation after zymosan or
curdlan treatment (Figures 5B and 5C), which do not bind to
Clec12a, as shown above. In contrast, MSU-induced ROS gen-
eration was substantially increased in the absence of Clec12a
(Figures 5B and 5C), which is consistent with the engagement
of Clec12a by MSU and the negative regulatory role of this re-
ceptor. To further characterize the role of Clec12a in the negative
regulation of MSU-mediated ROS production, we purified neu-
trophils from Clec12a/ and control animals. In line with the
results above, we observed a specific increase inMSU-triggered
ROS production, but not in zymosan-induced ROS generation in
purified Clec12a/ neutrophils (Figure 5D; data not shown),
demonstrating that Clec12a specifically downmodulates this
MSU response in vitro. ROS production in neutrophils requires
phosphorylation of the NADPH oxidase subunit p40phox (also
called NCF4) (Chessa et al., 2010). We tested and found
enhanced phosphorylation of p40phox specifically after MSU
treatment, but not after zymosan stimulation of Clec12a-defi-
cient cells (Figure 5E; Figure S3), demonstrating that Clec12a
inhibits MSU-induced signaling to p40phox phosphorylation.
Clec12a Counteracts Inflammatory Reactions to MSU
and Cell Death In Vivo
To study the function of Clec12a signaling in MSU-controlled
inflammatory pathways in vivo, we injected MSU crystals into
the peritoneum ofClec12a/mice. Compared withWT animals,
the Clec12a/ animals experienced a significantly increased
neutrophil influx upon treatment, demonstrating negative regu-
latory functions for Clec12a after MSU sensing in the intact
organism. The fact that LPS-induced neutrophil recruitment
was not significantly altered by Clec12a disruption excludes
nonspecific neutrophil recruitment defects in these mice (Fig-
ure 6A). Subsequently, we investigated the function of Clec12a
in the inflammatory responses to dead cells by first injecting
killed kidney cells into Clec12a-deficient mice. We observed
that these animals had an increased inflammatory reaction,
whichwasmeasured by a greatly increased number of infiltrating394 Immunity 40, 389–399, March 20, 2014 ª2014 Elsevier Inc.neutrophils compared to the WT mice (Figure 6B). In an alterna-
tive model of dead-cell-induced sterile inflammation, we X-ray
irradiated mice with 1 Gy to induce double-positive thymocyte
killing. In WT animals, this treatment results in the infiltration of
neutrophils into the thymus, which is positively regulated by
the Syk-coupled CLR Mincle (Uchimura et al., 2000; Yamasaki
et al., 2008). In the absence of Clec12a, we found that the infiltra-
tion of neutrophils was significantly enhanced (Figure 6C). More-
over, the expression of the chemokines CXCL1 and CXCL10 and
the inflammatory cytokine tumor necrosis factor alpha (TNF-a)
was increased in Clec12a-deficient animals (Figure 6D), collec-
tively demonstrating a negative regulatory role for Clec12a in
these sterile inflammatory reactions in vivo.
DISCUSSION
Our biochemical and genetic results define Clec12a as an inhib-
itory innate immune receptor for dead cells that recognizes the
danger signal MSUand regulates inflammatory responses.While
searching for specific Clec12a ligands, we observed that the
activation of Clec12a signaling can be downmodulated by a pro-
teinase pretreatment of killed cells before reporter cell stimula-
tion. Subsequently, we discovered that allopurinol also inhibits
the response and that both human and murine Clec12a can
physically bind to MSU crystals. Because the generation of
uric acid after cell death is an active process that requires
xanthine oxidase and that continues after cell injury (Kono
et al., 2010), it is likely that a proteinase treatment of killed cells
would inhibit thismechanism. However, we predict that Clec12a,
in addition to MSU, also binds protein ligands that are exposed
on dead cells. However, to date, we have failed to identify spe-
cific protein agonists that can stimulate Clec12a (data not
shown). Because the extracellular domains of both human and
murine Clec12a can bind to dead cells or MSU and the signaling
active fusion proteins of both human and mouse Clec12a induce
reporter cell activation after stimulation by dead cells or MSU,
this function of Clec12a is considered to be conserved among
species.
The identification of Clec12a as a specific receptor for MSU is,
to our knowledge, the first description of a transmembrane
immune receptor for which the direct binding to a crystal has
been shown. However, crystal-binding proteins have been
known for a long time; the most astounding are the antifreeze
proteins that are expressed in a variety of organisms, from bac-
teria to fish (Raymond and DeVries, 1977). The antifreeze pro-
teins adsorb to ice crystals, thereby blocking crystal growth.
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Figure 5. Clec12a Inhibits Neutrophil Acti-
vation by MSU
(A) Bone-marrow cells from WT mice were pre-
incubated with vehicle, 1 or 2 mM R406, and then
stimulated with 500 mg/ml MSU crystals in the
presence of 50 mM luminol. Emitted light was in-
tegrated over 30 min. The means of triplicates +
SD from one experiment, representative of three
independent experiments is shown. RLU, relative
light units.
(B) Clec12a-expressing (Clec12a+/) and Clec12a-
deficient bone-marrow cells were incubated with
500 mg/ml MSU crystals (left panel) or 25 mg/ml
zymosan (right panel) in the presence of 50 mM
luminol. Emitted light was recorded in 2 min in-
tervals for 40 min. The means of cells from three
individual mice per genotype + SD are shown.
(C) Integrated light units emitted within 40min from
bone-marrow cells left unstimulated or stimulated
with the indicated concentrations of MSU (left
panel) or the indicated concentrations of zymosan
or curdlan (right panel). The means of three mice
per genotype + SD are shown. Data are repre-
sentative of two independent experiments.
(D) Purified neutrophils from Clec12a+/ or
Clec12a/ mice were stimulated with 500 mg/ml
MSU and analyzed as in (B). The means of
triplicates + SD are shown. Data are representative
of three independent experiments.
(E) Purified neutrophils from Clec12a+/ or
Clec12a/ mice were stimulated with 500 mg/ml
MSU or 200 mg/ml Zymosan for the indicated
times. Lysates were subjected to immunoblot
analysis by using anti phospho-p40phox (Thr154).
Equal loading was verified by Ponceau staining.
See also Figure S3.
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Clec12a Senses Uric Acid CrystalsIntriguingly, several of these antifreeze molecules consist of a
single C-type lectin domain that is similar to mammalian CLRs
(Zelensky and Gready, 2005). These results indicate that this
domain can, in principle, bind crystalline surfaces. In the future,
it will be important to identify the exact structural determinants
within Clec12a that mediate MSU binding. Such results would
provide important general insights into the mechanisms of how
the innate immune system interacts with crystalline surfaces.
Prior to the identification of uric acid as aDAMP that is released
by or associated with killed cells (Shi et al., 2003), MSU was long
recognizedas thecausativeagentof gout.Highsystemicuricacid
levels are also frequently associated with cardiovascular disease
or diabetes mellitus (Rock et al., 2013). In gout, relatively large
MSU crystals form in the synovial fluid of joints and in other
locations, such as the kidney, leading to inflammation. The
phagocytosis of MSU particles and subsequent lysosomal dam-
age triggers the activation of the NLRP3 inflammasome, which
induces the maturation and secretion of the proinflammatory
cytokine IL-1b (Hornung et al., 2008; Martinon et al., 2006). In ex-
perimentswith isolated neutrophils andmacrophages,wedid not
observe the effects of the Clec12a deletion on MSU-induced IL-
1bproduction (data not shown), indicating that theNLRP3 inflam-
masome pathway is not directly affected by Clec12a signaling.
Thus, the mechanisms that drive NLRP3 activation after the
phagocytosis of MSU particles presumably operate in parallel to
other pathways emanating from Syk (Kool et al., 2011).As indicated above, MSU activates proinflammatory re-
sponses not only by triggering NLRP3 but also by directly acti-
vating Syk at the cell surface of innate immune cells through
ITAM-coupled CD11b/CD16 on neutrophils or induced lipid
sorting and the subsequent formation of cholesterol rich re-
gions that recruit ITAM-containing transmembrane adapters
on dendritic cells (Barabe´ et al., 1998; Ng et al., 2008). In vivo,
MSU is also found opsonized by complement components
and antibodies, which can trigger Syk-coupled complement
receptors and Fc receptors, respectively (Cherian and Schu-
macher, 1986; Terkeltaub et al., 1983). Our results demon-
strating that Clec12a inhibits Syk-dependent ROS production
induced by MSU suggest that Clec12a can counterbalance
these Syk activating ITAM signals. Consistent with this finding
and our discovery that Clec12a directly binds MSU crystals,
a current independent study reported enhanced tyrosine
phosphorylation, Ca2+ signaling and IL-8 production upon
MSU stimulation in a human neutrophil cell line after siRNA
knockdown of Clec12a (Gagne´ et al., 2013). Similarly, down-
regulation of Clec12a with a monoclonal antibody enhanced
the MSU-induced activation of human neutrophils. We
found that this antibody (clone 50C1) also reduces Clec12a
binding to MSU crystals (Figure S1), indicating that this anti-
body enhances neutrophil responses not merely by downre-
gulating Clec12a but directly interferes with Clec12a ligand
binding.Immunity 40, 389–399, March 20, 2014 ª2014 Elsevier Inc. 395
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Figure 6. Clec12a Regulates Sterile Inflam-
mation in Response to MSU or Cell Death
In Vivo
(A) WT and Clec12a-deficient mice were injected
with 400 mg of MSU or 1 mg of LPS into the peri-
toneum. Fourteen hours later, the numbers of
CD11b+Gr-1hi neutrophils in the peritoneum were
analyzed by flow cytometry. Data are the means +
SD of five mice per genotype and are representa-
tive of two independent experiments.
(B) WT and Clec12a-deficient mice were injected
with PBS or freeze-thawed kidney cells into the
peritoneum. Fourteen hours later, the numbers of
CD11b+Gr-1hi neutrophils in the peritoneum were
analyzed by flow cytometry. Data are means + SD
of five mice per group and are representative of
two independent experiments.
(C) WT and Clec12a-deficient mice were total
body-irradiated with 1 Gy of X-rays. Fourteen
hours later, the fraction and total cell number of
CD11b+Gr-1hi neutrophils in the thymus was
analyzed by flow cytometry. Data are means +
SEM of 12mice per group for irradiated and 5mice
per group for untreated.
(D) Thymus mRNA from the irradiated mice was
isolated and quantified by qPCR with primers
specific for the indicated chemokines and TNF-a
and normalized to the level of 18S RNA. (C) and
(D) Data are the means + SD of six mice per group
and are representative of two independent
experiments.
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Clec12a Senses Uric Acid CrystalsIt has been shown that ligands from dead cells can trigger the
Syk-activating CLRs Mincle and Clec9a (Sancho et al., 2009;
Yamasaki et al., 2008). Here, we reveal Clec12a as the first nega-
tive regulatory ITIM containing CLR for dead cell. These data
extend the importance of CLR sensing and signaling in innate im-
mune responses to cell death. In natural killer (NK) cells, the bal-
ance between ITAM and ITIM receptor signaling dictates the NK
cell response and can serve as a paradigm for the regulation of
innate immune recognition (Long, 2008). Our findings, together
with the established functions for CLRs, such as Mincle and
Clec9a, indicate that myeloid CLRs constitute a similar balanced
ITAM/ITIM receptor system that regulates inflammatory re-
sponses in response to dead cells. Indeed, the activation of
Mincle in response to radiation-induced sterile thymocyte death
mediates the infiltration of neutrophils (Uchimura et al., 2000;
Yamasaki et al., 2008). We found that this response is enhanced
in the absence of Clec12a, indicating the first in vivo relevance
of this ITAM/ITIM balance during sterile inflammation. Enhanced
sterile inflammatory responses were also observed after the
intraperitoneal injection of killed cells in the absence of Clec12a.
Whether these reactions are also dependent on Mincle or other
activating CLRs or direct Syk activation and whether Cle12a
ligands in addition to MSU are involved remains to be defined.
CLRs are not the only PRRs that control cell death-induced
inflammation. Other receptors, including TLRs, are also396 Immunity 40, 389–399, March 20, 2014 ª2014 Elsevier Inc.involved, and the distinct types of cell
death and subsequent release of a spe-
cific combinations of DAMPs is expected
to dictate the subsequent immuneresponse, which is important to maintain tissue homeostasis
after damage (Kaczmarek et al., 2013; Zitvogel et al., 2010).
However, the same pathways are thought to be key mecha-
nisms of inflammatory pathology in cases such as ischemic
reperfusion injury or toxic chemically induced tissue damage.
In these cases, TLRs and inflammasomes seem to cooperate
in inducing tissue-damaging inflammation (Eltzschig and Eckle,
2011; Imaeda et al., 2009). It will be important to investigate
the role of Clec12a in these pathologies, as crosstalk of Syk-
coupled receptors and TLRs have been described (Ivashkiv,
2009). Furthermore, it is widely believed that autoantibody pro-
duction in systemic lupus erythematosus is driven by defects
in dead cell clearance (Shao and Cohen, 2011). Moreover, given
that cell death is also a hallmark of infection by pathogens in vivo
(Matzinger, 1994), it is conceivable that Clec12a is also involved
in immune regulation under infectious conditions. The fact
that uric acid crystals are found in malaria in the Plasmodium
falciparum-infected red blood cells (van de Hoef et al., 2013)
and the finding that uric acid regulates adaptive immune
responses to this pathogen (Guermonprez et al., 2013) suggest
that Clec12a could be involved in such immune responses. Our
identification of Clec12a as an MSU and dead cell receptor will
provide a starting point for investigating the mechanisms and
contributions of Clec12a functions in host defense and immune
pathology.
Immunity
Clec12a Senses Uric Acid CrystalsEXPERIMENTAL PROCEDURES
Reagents
MSU crystals were from InvivoGen or crystallized from uric acid (U0881,
Sigma-Aldrich) under pyrogen-free conditions, as previously described
(Schiltz et al., 2002). All assays were performed with crystals from both sour-
ces. Rasburicase was from Sanofi-Aventis. CPPD crystals and Ultrapure
LPS from E. coli 0111:B4 were from InvivoGen. Polystyrene microspheres
(1 mm) were from Polysciences. Silica crystals (1.5 mm) were from Alfa Asar.
Allopurinol and zymosan were from Sigma. Curdlan was from Wako. Clec12a
antibody for Western Blot analysis was from R&D Systems, human Clec12a
monoclonal antibody (50C1) was from BioLegend. Phospho-p40phox
(Thr154) antibody was from Cell Signaling Technology. All of the antibodies
for FACS analysis were from eBiosciences, except anti-mouse Ly-6b.2 clone
7/4, which was from AbD Serotec. R406 was from Selleck Chemical. All of the
cell culture reagents were from Life Technologies. Fetal calf serum (FCS) was
used without heat inactivation.
Production of Recombinant CLR Extracellular Domains
The cDNAs encoding the extracellular domains of mouse Clec7a (NCBI:
NP_064392.2 amino acids [aa]: 75–244), mouse Clec9a (NCBI:
NP_001192292.1 aa: 63–264), mouse Clec12a (NCBI: NP_808354.1 aa: 67–
267) and human Clec12a (NCBI: NP_612210 aa 78–265aa) were amplified
by PCR and verified by sequencing. The cDNAs were fused to the C terminus
of human IgG1-Fc in the expression vector pFuse-hIgG1-Fc2 (InvivoGen).
CLR-Strep fusion constructs were generated by replacing the Fc part by a
Strep-tag II (IBA Life Sciences) Isoleucine Zipper cassette (Watzl, 2006) with
the protein sequence IHHHHHHGLSAWSHPQFEKGGGSGGGSGGGSWSH
PQFEKGRMKQIEDKIEEILSKIYHIENEIARIKKLIGERGIS.
Constructs were transfected into 293T cells, and secreted fusion proteins
were harvested 48 hr after transfection and adjusted to 5 mg/ml (Fc-fusion pro-
teins) or 0.5 mg/ml (Strep-tagged proteins) in DMEM with 10% FCS.
Generation of Reporter Cell Lines
The cDNA encoding the transmembrane and extracellular domains of
mouse Clec7a (NCBI: NP_064392.2 aa 44–244), mouse Clec9a (NCBI:
NP_001192292.1 aa 31–264), mouse Clec12a (NCBI: NP_808354.1 aa 41–
267) and human Clec12a (NCBI: NP_612210 aa 40–265) were amplified and
fused to the C terminus of the intracellular domain of murine CD3z
(NP_001106862.1, aa 52–164). A5 T cell hybridoma cells that contain an
NFAT-GFP expression cassette (Andersen et al., 2001; Bot et al., 1996) were
transfected with CLR-CD3z fusion proteins in pEF1 (Life Technologies) and
selected for G418 resistance and CLR surface expression.
Generation of Clec12a-Deficient Mice
A targeting vector was generated from 129J genomic DNA and was electropo-
rated into R1 embryonic stem cells. Homologous recombination replaced the
genomic fragment containing the first two exons encoding the intracellular
and transmembrane domain of Clec12a with a neomycin-resistance gene (Fig-
ure S1). Clones resistant to G418 were selected, and correctly recombined
cloneswere identifiedwith a Southern blot. Injection of two independent clones
into C57BL/6J blastocysts generated chimeric mice. Clec12a+/ mice were
identified by PCR and crossed to C57BL/6J for four to eight generations. Con-
trol mice on the same mixed genetic background were used. Experimental
groups of sex and age matched mice were cohoused for at least 3 weeks and
usedat anageof 8–12weeks.Micewere housed in theZentrum fu¨r Pra¨klinische
Forschung under specific pathogen-free conditions, according to Federation
of European Laboratory Animal Science Associations (FELASA) guidelines. All
animal experiments were approved by the Regierung von Oberbayern.
FACS Analysis of Splenocytes
Single-cell suspensions of spleen tissues were preincubated with Fc-block
(eBiosciences) and subsequently stained with propidium iodide and fluores-
cently labeled antibodies. Lymphoid cells were identified with antibodies
against B220, CD19, TCR-b, CD4, and CD8. Myeloid cells were identified
using antibodies against CD11b, F4/80, Gr-1, and Ly-6b.2 (7/4), as previously
described (Taylor et al., 2003). FACS data were acquired on a BD FACS Canto
II (BD Biosciences) and analyzed with FlowJo software (Tree Star).Staining with Recombinant CLR Fusion Proteins
All cells and particles were incubated with individual CLR-Fc fusion proteins
for 2 hr at 4C in DMEM containing 10% FCS, washed in PBS with 3% FCS,
incubated with anti-human IgG-PE (eBiosciences) in PBS with 3% FCS, and
analyzed with a flow cytometer (FACS Canto II, BD Biosciences). CLR-Strep
fusion proteins were used as Fc fusion proteins but detected with streptac-
tin-PE (IBA Life Sciences). For flow cytometric analysis, MSU crystals were
disrupted by ultrasound to create <5 mm crystals. To kill cells by freeze
thawing, we flash froze suspended cells in liquid nitrogen and thawed them
on ice. To degrade uric acid, dead cells were incubated with 0.3 mg/ml Raburi-
case for 90 min at 37C.
A5 Reporter Cell Stimulation
A5 reporter cells (Andersen et al., 2001; Bot et al., 1996) were grown in RPMI
1640 with 5% FCS and 50 mM b-MeOH and were stimulated with dead cell
preparations in complete growth medium for 18–20 hr, harvested, and stained
with anti-CD4-APC and 7-AAD (eBiosciences) to identify live A5 reporter cells.
Flow cytometry was used to examine GFP expression in the live (7-AAD)
reporter cells (CD4+). To analyze the GFP expression in response to particulate
stimuli, we washed cells in PBS and lysed them in PBS containing 0.1% NP-
40, and green fluorescence was analyzed with a Mithras LB 940 plate reader
(Berthold Technologies).
In Vitro Activation of Bone-Marrow Cells and Neutrophils
Untouched neutrophils were purified frombonemarrowwith a neutrophil isola-
tion kit (Miltenyi Biotech), according to the manufacturer’s recommendations.
Neutrophils or bone-marrow cells were resuspended at 0.5 3 107 or 1 3 107
cells per ml, respectively, in Opti-Mem I (GIBCO) containing 5% FCS and
they were plated in 96-well Luminometer plates (Nunc) blocked in 5% FCS
overnight. Cells were adjusted to 37C for 15 min and stimulated with
500 mg/ml MSU or 100 mg/ml zymosan in the presence of 50 mM luminol
(Sigma-Aldrich). Emitted light was recorded with a Mithras LB940 plate reader
every 3 min for 40 min.
Dead Cell- and MSU-Induced Peritonitis
Experiments were performed as previously described (Chen et al., 2006;
Yamasaki et al., 2008). Kidney cells were prepared by the digestion of WT
mouse kidneys with 200 U/ml of collagenase IV (GIBCO) for 45 min. Cells
were washed 23 with PBS, resuspended in 5 volumes of PBS, and killed
by freezing in liquid nitrogen and were then thawed at room temperature.
Kidney cells, 400 mg of MSU crystals, or 1 mg of LPS in 150 ml of PBS
were injected into the peritoneum of 8- to 12-week-old WT and Clec12a-defi-
cient sex- and age-matched mice. Fourteen hours later, the mice were
sacrificed, and their peritoneal cells were counted and analyzed by flow cy-
tometry with propidium iodide (PI), anti-CD11b, anti-Gr-1, and anti-Ly-6b.2
(clone 7/4). Viable neutrophils were identified as PI, Gr-1hi, Ly-6b.2int, and
CD11b+.
Neutrophil Infiltration after Total Body Irradiation
Analysis of neutrophil infiltration into the thymus of total body-irradiated (1 Gy)
mice was performed as previously described (Yamasaki et al., 2008). The
expression of inflammatory genes was analyzed with real-time PCR as
previously described (Lassen et al., 2010).
Statistical Analysis
An unpaired two-tailed Student’s t test was used for all of the statistical ana-
lyses. *p < 0.05, **p < 0.01, ns: not significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
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